144 related articles for article (PubMed ID: 24590433)
21. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.
Simone G; Bianchi M; Giannarelli D; Daneshmand S; Papalia R; Ferriero M; Guaglianone S; Sentinelli S; Colombo R; Montorsi F; Collura D; Muto G; Novara G; Hurle R; Rink M; Fisch M; Abol-Enein H; Miranda G; Desai M; Gill I; Gallucci M
World J Urol; 2015 Oct; 33(10):1419-28. PubMed ID: 25542395
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
24. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands.
Ali S; Palmer FL; Yu C; DiLorenzo M; Shah JP; Kattan MW; Patel SG; Ganly I
Ann Surg Oncol; 2014 Feb; 21(2):637-42. PubMed ID: 24132626
[TBL] [Abstract][Full Text] [Related]
25. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
[TBL] [Abstract][Full Text] [Related]
26. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?].
May M; Burger M; Brookman-May S; Otto W; Peter J; Rud O; Fritsche HM; Bolenz C; Trojan L; Herrmann E; Michel MS; Wülfing C; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Bretschneider-Ehrenberg P; Müller O; Zacharias M; Gunia S; Bastian PJ
Urologe A; 2011 Jun; 50(6):706-13. PubMed ID: 21340594
[TBL] [Abstract][Full Text] [Related]
27. Nodal staging score: a tool for survival prediction of node-negative bladder cancer.
Ku JH; Kim HH; Kwak C
Urol Oncol; 2013 Nov; 31(8):1731-6. PubMed ID: 23141779
[TBL] [Abstract][Full Text] [Related]
28. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
29. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
[TBL] [Abstract][Full Text] [Related]
30. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
31. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085
[TBL] [Abstract][Full Text] [Related]
32. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
[TBL] [Abstract][Full Text] [Related]
33. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
[TBL] [Abstract][Full Text] [Related]
34. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
35. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
36. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
Ferrone CR; Kattan MW; Tomlinson JS; Thayer SP; Brennan MF; Warshaw AL
J Clin Oncol; 2005 Oct; 23(30):7529-35. PubMed ID: 16234519
[TBL] [Abstract][Full Text] [Related]
37. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
[TBL] [Abstract][Full Text] [Related]
38. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
Rouprêt M; Hupertan V; Seisen T; Colin P; Xylinas E; Yates DR; Fajkovic H; Lotan Y; Raman JD; Zigeuner R; Remzi M; Bolenz C; Novara G; Kassouf W; Ouzzane A; Rozet F; Cussenot O; Martinez-Salamanca JI; Fritsche HM; Walton TJ; Wood CG; Bensalah K; Karakiewicz PI; Montorsi F; Margulis V; Shariat SF; ;
J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
[TBL] [Abstract][Full Text] [Related]
39. Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients.
Keck B; Wach S; Taubert H; Zeiler S; Ott OJ; Kunath F; Hartmann A; Bertz S; Weiss C; Hönscheid P; Schellenburg S; Rödel C; Baretton GB; Sauer R; Fietkau R; Wullich B; Krause FS; Datta K; Muders MH
Int J Cancer; 2015 Jan; 136(2):443-51. PubMed ID: 24862180
[TBL] [Abstract][Full Text] [Related]
40. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
